AMGN Competitors
Amgen Inc.
$460.42
+$0.14(+0.03%)
66
Overall
80
Value
66
Tech
52
Quality
Market Cap
$249.05B
Volume
2.58M
52W Range
$312.39 - $483.99
Target Price
$428.65
AMGN competitors: BMY, PFE, GSK, GILD, ABBV. Amgen Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
AMGN Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| BMY Bristol-Myers Squibb Company | $62.14 | $127.02B | $6.43 | 4.06% | 69 |
| PFE Pfizer Inc. | $29.39 | $167.52B | $3.01 | 4.39% | 76 |
| GSK GSK plc | $50.33 | $102.12B | $4.78 | 3.61% | 42 |
| GILD Gilead Sciences, Inc. | $166.89 | $207.00B | $-0.98 | 1.95% | 68 |
| ABBV AbbVie Inc. | $291.31 | $514.92B | $13.99 | 2.38% | 58 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AMGN | $460.42 | +0.0% | 2.58M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |